 |
|
Racial Differences in BRCA Testing—Reply
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
In Reply: We agree with Ms Alford and Dr Mouchawar that a case-control study, an efficient and powerful method for identifying risk factors for a rare outcome, requires careful attention to study design and sampling issues.1-2 These issues were addressed in several ways. First, we defined a source population from which both cases and controls were sampled. The source population was the University of Pennsylvania Health System’s primary care population. Second, we restricted the source population to women with a first- or second-degree relative with breast or ovarian cancer. This restriction limited the ability to generalize our findings to women without a family history of cancer (a small minority of whom have a BRCA1/2 mutation) but increased study efficiency by ensuring that BRCA1/2 mutation risk was relatively balanced between cases and controls. Restricting the source population to women at even greater risk of carrying a BRCA1/2 mutation would have narrowed . . . [Full Text of this Article]
Katrina Armstrong, MD, MSCE
karmstro@mail.med.upenn.edu
Ellyn Micco, BA;
Amy Badler, BA;
Jill Stopfer, MA;
Mary Putt, ScD
University of Pennsylvania School of Medicine
Philadelphia
RELATED ARTICLES
Racial Differences in BRCA Testing
Sharon Hensley Alford and Judy Mouchawar
JAMA. 2005;294(6):677.
EXTRACT
| FULL TEXT
Racial Differences in the Use of BRCA1/2 Testing Among Women With a Family History of Breast or Ovarian Cancer
Katrina Armstrong, Ellyn Micco, Amy Carney, Jill Stopfer, and Mary Putt
JAMA. 2005;293(14):1729-1736.
ABSTRACT
| FULL TEXT
|
